(Q81341430)
Statements
Endpoints and other considerations in phase I studies of targeted anticancer therapy: recommendations from the task force on Methodology for the Development of Innovative Cancer Therapies (MDICT) (English)
Christopher M Booth
A Hilary Calvert
Marinus W Lobbezoo
Lesley K Seymour
Elizabeth A Eisenhauer
24 September 2007